Table 2.
Relationship of Acute and Chronic GVHD to Serum IL-7 Levels
| GVHD | No. of Patients | % | Organ Involvement (No. of patients)
|
Median IL-7 Level (pg/mL)
|
|||
|---|---|---|---|---|---|---|---|
| Skin | Gut | Liver | Day +7 | Day +14 | |||
| Acute | |||||||
| None | 17 | 55 | 11.8 | 8.2 | |||
| Grade I | 1 | 3 | 1 | 0 | 0 | 23.9 | 14.0 |
| Grade II | 7 | 23 | 6 | 3 | 0 | 32.8 | 23.0 |
| Grade III | 6 | 19 | 3 | 5 | 2 | 25.7 | 27.8 |
| Grade IV | 0 | 0 | |||||
| Chronic | |||||||
| Yes | 21 | 68 | 12.82 | 12.42 | |||
| No | 8 | 26 | 24.85 | 12.27 | |||
| Not assessable | 2 | 6 | — | — | |||
Abbreviations: GVHD, graft-versus-host disease; IL, interleukin.